⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1572578 | 0.81 | LMNA (0.47) | — | |
| SCHEMBL14764616 | 0.75 | LMNA (0.35) | — | |
| SCHEMBL26025840 | 0.74 | ALDH1A1 (0.36) | — | |
| SCHEMBL7129194 | 0.73 | — | — | |
| SCHEMBL775367 | 0.73 | — | — | |
| SCHEMBL8420874 | 0.72 | — | — | |
| SCHEMBL10510540 | 0.71 | — | — | |
| SCHEMBL272723 | 0.71 | ALDH1A1 (0.32) | — | |
| SCHEMBL3505101 | 0.71 | LMNA (0.71) | — | |
| Hydrochloric Acid SCHEMBL17395694 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030069447-A1 | Acetal hydroxylamine compounds | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 2003-04-10 | — | — | US | claimed |
| EP-1255727-A1 | ACETAL HYDROXYLAMINE COMPOUNDS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 2002-11-13 | — | — | EP | claimed |
| WO-2001060785-A1 | ACETAL HYDROXYLAMINE COMPOUNDS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 2001-08-23 | — | — | WO | claimed |
| US-20230266666-A1 | SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-08-24 | — | — | US | disclosed |
| EP-2069291-B1 | HDAC INHIBITORS | GLAXOSMITHKLINE IP DEV LTD (GB) | 2017-12-20 | — | — | EP | disclosed |
| EP-2069291-B1 | HDAC INHIBITORS | GLAXOSMITHKLINE IP DEV LTD (GB) | 2017-12-20 | — | — | EP | disclosed |
| US-9725407-B2 | HDAC inhibitors | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2017-08-08 | — | — | US | disclosed |
| US-9725407-B2 | HDAC inhibitors | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2017-08-08 | — | — | US | disclosed |
| US-9725407-B2 | HDAC inhibitors | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2017-08-08 | — | — | US | disclosed |
| US-9636409-B2 | Enzyme and receptor modulation using covalent conjugates of alpha,alpha-disubstituted glycine esters | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2017-05-02 | — | — | US | disclosed |
| US-9636409-B2 | Enzyme and receptor modulation using covalent conjugates of alpha,alpha-disubstituted glycine esters | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2017-05-02 | — | — | US | disclosed |
| CN-1217932-C | Antibacterial agent | BRITISH BIOTECH PHARM (GB) | 2005-09-07 | — | — | CN | disclosed |
| US-20050065095-A1 | Antibacterial agents | BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) | 2005-03-24 | — | — | US | disclosed |
| US-6846825-B1 | Antibacterial agents | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 2005-01-25 | — | — | US | disclosed |
| US-20030069447-A1 | Acetal hydroxylamine compounds | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 2003-04-10 | — | — | US | disclosed |
| EP-1255727-A1 | ACETAL HYDROXYLAMINE COMPOUNDS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 2002-11-13 | — | — | EP | disclosed |
| CN-1373754-A | Antibacterial agent | BRITISH BIOTECH PHARM (GB) | 2002-10-09 | — | — | CN | disclosed |
| EP-1202968-A2 | ANTIBACTERIAL AGENTS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 2002-05-08 | — | — | EP | disclosed |
| WO-2001060785-A1 | ACETAL HYDROXYLAMINE COMPOUNDS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 2001-08-23 | — | — | WO | disclosed |
| WO-2001010834-A2 | ANTIBACTERIAL AGENTS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 2001-02-15 | — | — | WO | disclosed |